Skip to content

Clinical trials

Completed Demyelinating Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Status: Completed Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20041
20061
20072
20081
20091
20101
20111
20154
20161
20171
20181
20191
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)6
Acorda Therapeutics4
Alexion Pharmaceuticals, Inc.2
Baxalta now part of Shire1
Dragonfly Research, LLC1
EMD Serono1
Kristin Zhao, PhD1
MedImmune LLC1
Novartis Pharmaceuticals1
Ohio State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases27
Multiple Sclerosis18
Autoimmune Diseases8
Autoimmune Diseases of the Nervous System7
Nervous System Diseases7
Demyelinating Autoimmune Diseases, CNS6
Immune System Diseases6
Multiple Sclerosis, Relapsing-Remitting5
Neuromyelitis Optica4
Pathologic Processes3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.